Chabiotech Co.,Ltd. (KOSDAQ:085660)
South Korea flag South Korea · Delayed Price · Currency is KRW
17,260
-270 (-1.54%)
Apr 29, 2026, 11:43 AM KST

Chabiotech Revenue

In the year 2025, Chabiotech had annual revenue of 1.27T KRW with 21.36% growth. Chabiotech had revenue of 346.54B in the quarter ending December 31, 2025, with 25.57% growth.

Revenue
1,268.25B
Revenue Growth
+21.36%
P/S Ratio
1.28
Revenue / Employee
4.56B
Employees
278
Market Cap
1,621.51B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20251,268.25B223.20B21.36%
Dec 31, 20241,045.05B91.10B9.55%
Dec 31, 2023953.95B109.37B12.95%
Dec 31, 2022844.58B117.11B16.10%
Dec 31, 2021727.48B62.76B9.44%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Orum Therapeutics 23.56M
Pharmicell 23.94B
MEDIPOST 73.66B
GI Innovation 5.84B
Onconic Therapeutics 53.39B
Hugel 425.11B
PharmaResearch 536.29B
SK bioscience 651.37B
Revenue Rankings